ZA892270B - Mutant human angiogenin(angiogenesis factor with superior angiogenin activity)genes therefor and methods of expression - Google Patents

Mutant human angiogenin(angiogenesis factor with superior angiogenin activity)genes therefor and methods of expression

Info

Publication number
ZA892270B
ZA892270B ZA892270A ZA892270A ZA892270B ZA 892270 B ZA892270 B ZA 892270B ZA 892270 A ZA892270 A ZA 892270A ZA 892270 A ZA892270 A ZA 892270A ZA 892270 B ZA892270 B ZA 892270B
Authority
ZA
South Africa
Prior art keywords
angiogenin
proteins
mutant
activity
angiogenic
Prior art date
Application number
ZA892270A
Other languages
English (en)
Inventor
Jeffrey W Harper
W Harper Jeffrey
Bert L Vallee
L Vallee Bert
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of ZA892270B publication Critical patent/ZA892270B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA892270A 1988-03-28 1989-03-28 Mutant human angiogenin(angiogenesis factor with superior angiogenin activity)genes therefor and methods of expression ZA892270B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/173,760 US4900673A (en) 1988-03-28 1988-03-28 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression

Publications (1)

Publication Number Publication Date
ZA892270B true ZA892270B (en) 1991-12-24

Family

ID=22633370

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892270A ZA892270B (en) 1988-03-28 1989-03-28 Mutant human angiogenin(angiogenesis factor with superior angiogenin activity)genes therefor and methods of expression

Country Status (13)

Country Link
US (1) US4900673A (xx)
EP (1) EP0335243B1 (xx)
JP (1) JPH03503641A (xx)
KR (1) KR900700609A (xx)
AT (1) ATE96844T1 (xx)
AU (1) AU621358B2 (xx)
CA (1) CA1331356C (xx)
DE (1) DE68910354T2 (xx)
DK (1) DK233390A (xx)
IE (1) IE890954L (xx)
PT (1) PT90129A (xx)
WO (1) WO1989009277A1 (xx)
ZA (1) ZA892270B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520914A (en) * 1987-08-06 1996-05-28 President And Fellows Of Harvard College Antibodies to angiogenin: immunotherapeutic agents
IL96519A0 (en) * 1990-02-15 1991-08-16 Harvard College Covalent angiogenin/rnase hybrids
DE4309391C2 (de) * 1993-03-23 1996-10-24 Harald Prof Dr Tschesche Verwendung von Angiogenin und/oder dessen Fragmenten als Wirkstoff zur Verhinderung oder Begrenzung der Sekretion von Proteinen aus Leukozyten
WO2001019987A1 (en) * 1999-09-13 2001-03-22 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
CA2246332C (en) 1996-02-15 2009-04-14 Biosense, Inc. Catheter based surgery
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
WO2001040464A1 (en) * 1999-11-30 2001-06-07 Genentech, Inc. Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization
WO2000073445A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Interleukin-1-receptor associated kinase-3 (irak3)
US5852001A (en) * 1996-12-23 1998-12-22 The Endowment For Research In Human Biology Method and compounds for inhibition of ribonucleases
US20030129750A1 (en) * 1998-02-05 2003-07-10 Yitzhack Schwartz Homing of donor cells to a target zone in tissue using active therapeutics or substances
EP1563866B1 (en) 1998-02-05 2007-10-03 Biosense Webster, Inc. Intracardiac drug delivery
US20030113303A1 (en) * 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
US6211157B1 (en) 1998-05-01 2001-04-03 Sulzer Biologics, Inc. Protein mixtures to induce therapeutic angiogenesis
IL141537A0 (en) * 1998-09-14 2002-03-10 Genentech Inc Promotion or inhibition of angiogenesis and cardiovascularization
US6992066B2 (en) * 1998-10-16 2006-01-31 Zimmer Orthobiologics, Inc. Povidone-containing carriers for polypeptide growth factors
US7087577B2 (en) * 1998-10-16 2006-08-08 Zimmer Orthobiologies, Inc. Method of promoting natural bypass
EP1734051A3 (en) * 1998-12-01 2007-09-12 Genetech, Inc. Composition and methods for the diagnosis of tumours
JP3695642B2 (ja) * 1998-12-01 2005-09-14 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
AU2600800A (en) * 1999-03-08 2000-09-28 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization
JP2003531811A (ja) * 1999-03-08 2003-10-28 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
AU2596700A (en) * 1999-03-08 2000-09-28 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization
US6743600B1 (en) 1999-04-30 2004-06-01 Monsanto Technologies Llc Method of removing N-terminal alanine residues from polypeptides with Aeromonas aminopeptidase
US6794159B1 (en) * 1999-04-30 2004-09-21 Pharmacia Corporation Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase
AU2001278852A1 (en) * 2000-06-23 2002-01-08 Genentech Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US7232802B2 (en) 2001-12-21 2007-06-19 Zimmer Orthobiologics, Inc. Compositions and methods for promoting myocardial and peripheral angiogenesis
WO2004106491A2 (en) * 2003-05-22 2004-12-09 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Angiogenin-based hiv-1 therapies
GB0425625D0 (en) 2004-11-22 2004-12-22 Royal College Of Surgeons Ie Treatment of disease
US8828698B2 (en) * 2007-04-12 2014-09-09 Naidu Lp Immobilized angiogenin mixtures and uses thereof
US7601689B2 (en) 2007-04-12 2009-10-13 Naidu Lp Angiogenin complexes (ANGex) and uses thereof
WO2011062762A2 (en) * 2009-11-19 2011-05-26 President And Fellows Of Harvard College Angiogenin and variants thereof for treatment of neurodegenerative diseases
CN115947818A (zh) * 2022-10-25 2023-04-11 福州大学 一种血管生成素1突变体的设计及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721672A (en) * 1985-08-28 1988-01-26 President And Fellows Of Harvard College CDNA and gene for human angiogenin (angiogenesis factor) and methods of expression
ES2056787T3 (es) * 1985-12-17 1994-10-16 Synergen Inc Factor angiogenico de placenta humana capaz de estimular la sintesis capilar de proteasa de celulas endoteliales, la sintesis de adn y la migracion.
FR2623509B1 (fr) * 1987-11-19 1990-04-20 Centre Nat Rech Scient Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments

Also Published As

Publication number Publication date
DE68910354D1 (de) 1993-12-09
AU3433189A (en) 1989-10-16
JPH03503641A (ja) 1991-08-15
EP0335243A3 (en) 1989-11-23
EP0335243B1 (en) 1993-11-03
PT90129A (pt) 1989-11-10
KR900700609A (ko) 1990-08-16
ATE96844T1 (de) 1993-11-15
AU621358B2 (en) 1992-03-12
CA1331356C (en) 1994-08-09
WO1989009277A1 (en) 1989-10-05
US4900673A (en) 1990-02-13
EP0335243A2 (en) 1989-10-04
DK233390D0 (da) 1990-09-27
IE890954L (en) 1989-09-28
DK233390A (da) 1990-11-26
DE68910354T2 (de) 1994-03-03

Similar Documents

Publication Publication Date Title
EP0335243A3 (en) Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
EP0155188A3 (en) Alpha-1-antitrypsin mutants and dna coding therefor and the production of each, and therapeutic formulations using such mutants and their preparation
SE9102079L (sv) Renad ciliaer neurotropisk faktor
IL87025A (en) Recombinant human basic fibroblast growth factor analogs, their production, dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences
HK1008049A1 (en) Transduced fibroblasts and use therefor
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
EP0437610A4 (en) Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide
FR2730504B1 (fr) Procede de preparation de genomes d'adenovirus recombinants
NZ239357A (en) Human mk gene and protein sequence
DE3854456T2 (de) Charakterisierung und Struktur der Gene für Protease A und Protease B von Streptomyces griseus.
WO2000063415A8 (en) Dna encoding the human vanilloid receptor vr1
IL88034A0 (en) Mutant acidic fibroblast growth factor,its preparation and pharmaceutical compositions containing it
IL88371A0 (en) Directed integration of genes into a plant genome and recombinant dna,expression vectors and host cells used therefor
CA2245584A1 (en) Recombinant expression of s-layer proteins
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
HUT62327A (en) Process for producing somatotropins modified in their alfa-helix 1 region and their combination with other mutants
EP1272514A4 (en) DNA ENCODING THE HUMAN RECEPTOR OF VANILLOIDE VR3
EP0274560A3 (en) Human hematopoietic cell growth potentiating factor
ZA887950B (en) Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions
EP0267779A3 (en) Human pleiotropic immune factor and muteins thereof
DE69533840D1 (de) Verbesserter expressionsvektor für die herstellung rekombinanter proteine
ES8800350A1 (es) Procedimiento para preparar una cepa microbiana transformada mediante un plasmido recombinante.
AU5966790A (en) Genetic elements useful in production of active protein
Lecadet et al. Structure and activity of the B. thuringiensis delta-endotoxin. Recent development in genetics.